ArticleFrontiers in neuroscience2026
FNR-like unit interacts with C-terminal related residues trigger nNOS reductase domain conformational flexibility change.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The reductase domain of neuronal nitric oxide synthase (nNOS) is essential for nitric oxide (NO) production in the mammalian nervous system. Excessive NO contributes to neurological disorders, including ischemic stroke, highlighting the need to better understand the structural dynamics of this domain. The FNR- like unit within the reductase domain stabilizes the cofactors NADP(H), FAD, and FMN, which are critical for NO synthesis. However, the dynamic interactions between these cofactors and key residues remain poorly characterized, limiting the ability of current nNOS inhibitors to normalize enzyme activity in cerebral ischemia-reperfusion injury. Methods: In this study, we evaluated the effects of widely used nNOS inhibitors, including spermidine (Spe) and L-NMMA, on nNOS activity using cellular NO assays and Western blot analysis. To investigate the structural basis of this resistance, we constructed three molecular models representing distinct redox states of NADP(H), FAD, and FMN, and derived new parameters for these cofactors (oxidized and reduced forms) using the def2-TZVP basis set. Results: While those inhibitors showed some therapeutic benefit in ischemia-reperfusion injury, they failed to suppress nNOS activity to physiological levels. RMSD analysis confirmed conformational stability after ~1.0 μs of simulation. Hydrogen bond and polar contact analyses identified R1400, R1284, R1173, and F1395 as key residues stabilizing cofactor binding in the FNR-like unit. RMSF analysis revealed low flexibility of these residues, supporting structural integrity. Correlation and free energy calculations further demonstrated their critical contributions to the energy landscape. In silico site-directed mutagenesis of these residues induced significant free energy changes, confirming their role in modulating domain dynamics. Notably, R1400 and F1395, previously associated with the calmodulin-binding domain, influence conformational flexibility, while R1173 represents a novel interaction hotspot distinct from R1284. Discussion: These results provide detailed insights into the dynamic mechanisms of the FNR-like unit and identify promising targets for the development of improved nNOS inhibitors to control excessive NO production in neurological disorders such as ischemic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.